Genetics of congenital hypothyroidism

Journal of Medical Genetics

Volumn 42, Issue 5, 2005, Pages 379-389

  Park, S M ^a   Chatterjee, V K K ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; IODINE 125; IODOTHYRONINE TRANSPORTER; LIOTHYRONINE; OXIDOREDUCTASE; PENDRIN; RADIOACTIVE IODINE; SODIUM IODIDE I 125; SODIUM IODIDE I 131; SODIUM IODIDE SYMPORTER; TECHNETIUM; THYROGLOBULIN; THYROID OXIDASE 2; THYROID PEROXIDASE; THYROID TRANSCRIPTION FACTOR 1; THYROID TRANSCRIPTION FACTOR 2; THYROTROPIN RECEPTOR; THYROXINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX8; UNCLASSIFIED DRUG;

CONGENITAL HYPOTHYROIDISM; DEVELOPMENTAL DISORDER; GENE; GENE MUTATION; GENETICS; GSALPHA GENE; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; INFERTILITY; NERVOUS SYSTEM DEVELOPMENT; NIS GENE; NONHUMAN; PAX 8 GENE; PDS GENE; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; TG GENE; THOX2 GENE; THYROID FUNCTION TEST; THYROID GLAND; THYROID SCINTISCANNING; TITF 1 GENE; TITF 2 GENE; TPO GENE;

AMINO ACID SEQUENCE; CONGENITAL HYPOTHYROIDISM; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; RECEPTORS, THYROTROPIN; REPRESSOR PROTEINS; THYROID DYSGENESIS; THYROID HORMONES;

EID: 18844400822     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.024158     Document Type: Review

References (135)

1. Toublanc J. Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts of the world. Horm Res (Basel) 1992;38:230-5.
2. Grant DB, Smith I, Fuggle PW, Tokar S, Chapple J. Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early clinical features. Arch Dis Child 1992;67:87-90.
3. Medeiros-Neto G, Stanbury JB, eds. Inherited disorders of the thyroid system. Boca Raton: CRC Press, 1994:1-221.
4. Pintar JE. Normal development of the hypothalamic-pituitary-thyroid axis. In: Braverman LE, Utiger RD, eds. Werner and Ingbor's the thyroid, 7th ed. Philadelphia: Lippincott-Raven, 1996:6-18.
5. Williams E, Toyn C, Harach H. The ultimobranchial gland and congenital thyroid abnormalities in man. J Pathol 1989;159:135-41.
6. Cao XY, Jiang XM, Dou ZH, Rakeman MA, Zhang ML, O'Donnell K, Ma T, Amette K, DeLong N, DeLong GR. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. N Engl J Med 1994;331:1739-44.
7. Klein RZ, Mitchell ML. Hypothyroidism in infants and children. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid, 7th ed. Philadelphia: Lippincott-Raven, 1990:984-1008.
8. Castanet M, Polak M, Bonaiti-Pellie C, Lyonnet S, Czernickow P, Leger J. Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 2001;86:2009-14.
9. Grant DB, Smith I. Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4. BJM 1988;296:1355-8.
10. Law WY, Bradley DM, Lazarus JH, John R, Gregory JW. Congenital hypothyroidism in Wales (1982-1993): demographic features, clinical presentation and effects on early neurodevelopment. Clin Endocrinol (Oxf) 1988;48:201-7.
11. Strader CD, Fong TM, Tola MR, Underwood D, Structure and function of G protein-coupled receptors. Annu Rev Biochem 1994;63:101-32.
12. Vassart G, Dumont JE. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrinol Rev 1992;13:596-611.
13. Libert F, Passage E, Lefort A, Vassar G, Mattei MG. Localisation of human thyrotropin receptor gene to chromosome region 14q31 by in situ hybridization. Cytogenet Cell Genet 1990;54:82-3.
14. Gross B, Misrahi M, Sar S, Milgrom E. Composite structure of the human thyrotropin receptor gene, Biochem Biophys Commun 1991;177:679-87.
15. Damante G, Di Lauro R. Thyroid-specific gene expression, Biochem Biophys Acta 1994;1218:255-66.
16. Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S. Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 1994;8:129-38.
17. Postiglione MP, Parlato R, Rodiguez-Mallon A, Rosica A, Mithbaokor P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R. Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 2002;99:15462-7.
18. Evans C, Jordan NJ, Owens G, Bradley D, Ludgate M, John R. Potent thyrotrophin receptor-blocking antibodies: a cause of transient congenital hypothyroidism and delayed thyroid development. Eur J Endocrinol 2004;150:265-8.
19. Sunthornmepvarakul T, Gootschalk ME, Hayashi Y, Refetoff S. Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 1995;332:155-60.
20. De Roux N, Misrahi M, Brauner R, Houang M, Carel JC, Granier M, Le Bouc Y, Ghinea N, Boumeddienne A, Toublanc JE, Milgrom E. Four families with loss of function mutations of the thyrotropin receptor J Clin Endocrinol Metabol 1996;81:4229-35.
21. Clifton-Bligh RJ, Gregory JW, Ludgate M, John R, Persani L, Asteria C, Beck-Peccoz P, Chatterjee VKK. Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH. J Clin Endocrinol Metabol 1997;82:1094-100.
22. Biebermann H, Schoneberg T, Krude H, Schuktz G, Gudermann T, Gruters A. Mutations in the numan thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism. J Clin Endocrinol Metabol 1997;82:3471-80.
23. Abramowicz MJ, Duprez L, Parma J, Vassart G, Heinrich C. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 1997;99:3018-24.
24. Gagne N, Parma J, Deal C, Vassart G, Van Vliet G. Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities? J Clin Endocrinol Metabol 1998;83:1771-5.
25. Tiosano D, Pannain S, Vassart G, Parmo J, Gershoni-Baruch R, Mandel H, Lotan, R, Zaharan Y, Pery M, Weiss R, Refetoff S, Hochberg, Z. The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid 1999;9:887-94.
26. Tonacchera M, Agretti P, Pinchera A, Rosellini V, Perri, A, Collecchi P, Vitti P, Chiovato L. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. J Clin Endocrinol Metab 2000;85:1001-8.
27. Russo D, Betterle C, Arturi F, Chiefari E, Girelli ME, Filetti S. A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH. J Clin Endocrinol Metab 2000;85:4238-42.
28. Bretones P, Duprez L, Parma J, David M, Vassart G, Rodien P. A familial case of congenital hypothyroidism caused by a homozygous mutation of the thyrotropin receptor gene. Thyroid 2001;11:997-8.
29. Nagashima T, Murakami M, Onigata K, Morimura T, Nagashima K, Mori M, Morikawa A. Novel inactivating missense mutations in the thyrotropin receptor gene in Japanese children with resistance to thyrotropin. Thyroid 2001;11:551-9.
30. Tonacchera M, Agretti P, De Marco G, Perri A, Pinchera A, Vitti P, Chiovato L. Thyroid resistance to TSH complicated by autoimmune thyroiditis. J Clin Endocrinol Metab 2001;86:4543-6.
31. Alberti L, Proverbio MC, Costagliola S, Romoli R, Boldrighini B, Vigone MC, Weber G, Chiumello G, Beck-Peccoz P, Persani L. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism. J Clin Endocrinol Metab 2002;87:2549-55.
32. Park SM, Clifton-Bligh RJ, Betts P, Chatterjee VK. Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor. Clin Endocrinol (Oxf) 2004;60:220-7.
33. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G, Somatic mutation in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993;365:649-51.
34. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoolx M, Orgiazzi J, Dumont J, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet 1994;7:396-401.
35. Jordan N, Williams N, Gregory JW, Evans C, Owen M, Ludgate M. The W546X mutation of the thyrotropin receptor gene: potential major contributor to thyroid dysfunction in a Caucasian population. J Clin Endocrinol Metab 2003;88:1002-5.
36. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997;16:3185-97.
37. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, Pischetola M, Taylor BA, Phillips SJ, Simeone A, Di Lauro R. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation [erratum]. EMBO J 2001;20:2108.
38. Hishinuma A, Ohyama Y, Kuribayashi T, Nagakubo N, Namatame T, Shibayama K, Arisaka O, Matsuura N, Ieiri T. Polymorphism of the polyalanine tract of thyroid transcription factor-2 gene in patients with thyroid dysgenesis. Eur J Endocrinol 2001;145:385-9.
39. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp M, John R, Lazarus JH, Ludgate M, Chatterjee VKK. Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 1998;19:399-401.
40. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, Anastassiadis K, Macchia PE, Mattei M-G, Mariano A, Scholer H, Macchia V, Di Lauro R. A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 1998;19:395-8.
41. Dathan N, Parlato R, Rosica A, De Felice M, Di Lauro R. Distribution of the titf2/foxe1 gene product is consistent with an important role in the development of foregut endoderm, palate, and hair. Dev Dyn 2002;224:450-6.
42. Sequeira M, Al-Khafaji F, Park S, Lewis MD, Wheeler MH, Chatterjee VK, Jasani B, Ludgate M. Production and application of polyclonal antibody to human thyroid transcription factor 2 reveals thyroid transcription factor 2 protein expression in adult thyroid and hair follicles and prepubertal testis. Thyroid 2003;13:927-32.
43. Bamforth JS, Hughes IA, Lazarus JH, Weaver CM, Harper PS. Congenital hypothyroidism, spiky hair, and cleft palate. J Med Genet 1989;26:49-60.
44. Castanet M, Park SM, Smith A, Bost M, Leger J, Lyonnet S, Pelet A, Czernichow P, Charrerjee K, Polak M. A novel loss-of-function mutation in TTF-2 is associated with congenital hypothyroidism, thyroid agenesis, and cleft palate. Hum Mol Genet 2002;11:2051-9.
45. Harvey RP. NK-2 homeobox genes and heart development. Dev Biol 1996;187:203-16.
46. Scott MP, Tamkun JW, Hatzell GW. The structure and function of the homeodomain. Biochim Biophys Acta 1989;989:25-48.
47. De Felice M, Damante G, Zannini M, Francis-Lang H, Di Lauro R. Redundant domains contribute to the transcriptional activity of thyroid transcription factor 1. J Biol Chem 1995;270:26649-56.
48. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, Di Lauro R. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631-9.
49. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ. The t/epb null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain and pituitary. Genes Dev 1996;10:60-9.
50. Breedveld GJ, van Dongen JWF, Danesino C, Guala A, Percy AK, Dure LS, Harper P, Lazarou LP, et al. Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 2002;11:971-9.
51. Lazzaro D, Price M, de Felice M, Di Lauro R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093-104.
52. Civitreale D, Lonigro R, Sinclair AJ, Di Lauro R. A thyroid-specific nuclear protein essential for tissue-specific expression of the tnyroglobulin promoter. EMBO J 1989;8:2537-42.
53. Francis-Lang H, Price M, Polycarpou-Schwarte M, Di Lauro R. Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Mol Cell Biol 1992;12:576-88.
54. Bruno MD, Bohinski RJ, Huelsmon KM, Whitsett JA, Korfhagen TR. Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 1995;270:6531-6.
55. Devriendt K, Vonhole C, Motthijs G, de Zegher F. Deletion of the thyroid transcription factor-1 gene in on infant with neonotal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:1317-18.
56. Iwatani N, Mobe H, Devriendt K, Kodamo M, Miike T. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediotr 2000;137:272-6.
57. Doyle DA, Gonzalez I, Thomos B, Scovino M. Autosomol dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and atoxia caused by o mutation of NKX2-1. J Pediatr 2004;145:190-3.
58. Pohlenz J, Dumitrescu A, Zundel D, Martine U, Schonberger W, Koo E, Weiss RE, Cohen RN, Kimuro S, Refetoff S. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002;109:469-73.
59. Krude H, Schutz, Biebermann H, von Moers A, Schnabel D, Neitzel H, Tonnies H, Weise D, Lafferty A, Schwarz S, DeFelice M, von Deimling A, van Landeghem F, DiLauro R, Gruters A. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109:475-80.
60. Stuart ET, Gruss P. PAX genes: what's new in developmental biology and cancer? Hum Mol Genet 1995;4:1717-20.
61. Mansouri A, Hallonet M, Gruss P. Pax genes and their role cell differentiation and development. Curr Opin Cell Biol 1996;8:851-7.
62. Poleev A, Fickenscher H, Mundlos S, Winterpacht A, Zabel B, Fidler A, Gruss P, Plachov D. PAX-8, a human paired box gene: isolation and expression in developing thyroid, kidney, and Wilm's tumours. Development (Camb) 1992;116:611-23.
63. Poleev A, Wendler F, Gickenscher H, Zannini S, Yaginuma K, Abbott C, Plachov D. Distinct functional properties of three human paired-box-proteins, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors. Eur J Biochem 1995;228:899-911.
64. di Magliano MP, Di Lauro R, Zannini M. Pax8 has a key role in thyroid cell differentiation. Proc Natl Acad Sci USA 2000;97:13144-9.
65. Mansouri A, Chowdhury K, Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 1998;19:87-90.
66. Macchia PA, Lapi P, Krude H, Pirro MT, Missero C, Chiovato L, Souabni A, Baserga M, Tassi V, Pinchera A, Fenzi G, Gruters A, Busslinger M, Di Lauro R. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 1998;19:83-6.
67. Vilain C, Rydlewski C, Dupez L, Heinrichs C, Abramowicz, Malvaux P, Renneboog B, Parmo J, Costagliola S, Vassart G. Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. J Clin Endocrinol Metab 2001;86:234-8.
68. Congdon T, Nguyen LQ, Nogueiro CR, Habiby RL, Medeiros-Neto G, Kopp P. A novel mutation (Q40) in PAX8 associated with congenital hypothyroidism and thyroid hypoplosio: evidence for phenotypic variability in mother and child. J Clin Endocrinol Metab 2001;86:3962-7.
69. Meeus L, Gilbert B, Rydlewski C, Parmo J, Roussie AL, Abramowicz M, Vilain C, Christophe D, Costagliola S, Vassort G. Characterization of o novel loss of function mutation of PAX8 in fomiliol case of congenital hypothyroidism with in-place, normal-sized thyroid. J Clin Endocrinol Metab 2004;89:4285-91.
70. Fraizer GC, Shimamura R, Zhang X, Saubders GF. PAX8 regulates human WT1 transcription through a novel DNA binding site. J Biol Chem 1997;272:30678-87.
71. Ohno M, Zannini M, Levy O, Carrasco N, Di Lauro R. The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/ iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 1999;19:2051-60.
72. Espinoza CR, Schmitt TL, Loos U. Thyroid transcription factor 1 and Pax8 synergistically activate the promoter of human thyroglobulin gene. J Mol Endocrinol 2001;27:59-67.
73. sα gene. Proc Natl Acad Sci USA 1988;85:2081-5.
74. Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutation 2000;16:183-9.
75. sα gene mutations in Albright's hereditary osteodystrophy. J Med Genet 1994;31:835-9.
76. Yu D, Yu S, Schuster V, Kruse K, Clericuzio CL, Weinstein LS. Identification of two novel deletion mutations within the Gs alpha gene (GNAS1) in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 1999;84:3254-9.
77. de Viilder JJM, Vulsma T. Hereditary Metabolic Disorders causing hypothyroidism. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid, 7th ed. Philadelphia: Lippincott-Raven, 1996:749-55.
78. Endo Y, Onogi S, Umeki K, Yamamoto I, Kotani T, Ohtaki S, Fujita T. Regional localization of the gene for thyroid peroxidase to human chromosome 2p25 and mouse chromosome 12C. Genomics 1995;25:760-1.
79. Mangkalbruks A, Correa Billerbeck A-E, Wajchenberg B, Knobel M, Cox NJ, DeGroot LJ, Medeiros-Neto G. Genetic linkage studies of thyroid peroxidase (TPO) gene in families with TPO deficiency. J Clin Endocrinol Metab 1991;72:471-6.
80. Bikker H, Vulsma T, Baas F, de Vijlder JJM. Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis. Hum Mutat 1995;6:9-16.
81. Abramowicz MJ, Targovnik HM, Varela V, Cochaux P, Krawiec L, Pisorev MA, Propoto FV, Juvenol G, Chester HA, Vossart G. Identification of a mutation in the coding sequence of the human thyroid peroxidose gene causing congenital goiter. J Clin Invest 1992;90:1200-4.
82. Bikker H, den Hortog MT, Baas F, Gons MH, Vulsma T, de Vijlder JJ. A 20-bosepair duplication in the humon thyroid peroxidase gene results in a total iodide organisation defect and congenital hypothyroidism. J Clin Endocrinol Metab 1994;79:248-52.
83. Bikker H, Waelkens JJJ, Bravenboer B, de Vijlder JJJ. Congenitol hypothyroidism caused by a premature termination signal in exon 10 of the human thyroid peroxidase gene. J Clin Endocrinol Metabol 1996;81:2076-9.
84. de Vijlder JJM, Bikker H, Ris-Stolpers C, Vulsmo T. Structure, function, and relevance of thyroid peroxidose in inherited diseases of the thyroid. Curr Opin Endocrinol Diabetes 1997;4:328-32.
85. Medeiros-Neto G, Gil-do-Costa MJ, Santos CS, Medina AM, Silvo JCE, Tsou RM, Sobrinho-Simoes M. Metastotic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidose gene. J Clin Endocrinol Metab 1998;83:4162-6.
86. Kotani T, Umeki K, Yamaoto I, Maesaka H, Tachibana K, Ohtaki S. A novel mutation in the human thyroid peroxidase gene resulting in a total iodide organification defect. J Endocrinol 1999;160:267-73.
87. Kotani T, Umeki K, Yamamoto I, Ohtaki S, Adachi M, Tachibana K. Iodide organisation defects resulting from cosegregation of mutated and null thyroid peroxidase alleles. Mol Cell Endocrinol 2001;182:61-8.
88. Pannain S, Weiss RE, Kackson CE, Dian D, Beck JC, Sheffield VC, Cox N, Refetoff S. Two different mutations in the thyroid peroxidase gene of a large inbred Amish kindred: power and limits of homozygosity mapping. J Clin Endocrinol Metab 1999;84:1061-71.
89. Santos CL, Rego KG, Nascimento AC, Tambascia M, de Vijlder JJ, Medeiros-Neto G. A novel mutation in the TPO gene in goitrous hypothyroid patients with iodide organification defect. Clin Endocrinol (Oxf) 1999;51:165-72.
90. Bakker B, Bikker H, Vulsma T, de Randamie JSE, Wiedijk BM, de Vijlder JJM. Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 2000;85:3708-12.
91. Ambrugger P, Stoeva I, Biebermann H, Torresani T, Leitner C, Gruter A. Novel mutations of the thyroid peroxidase gene in patients with permanent congenital hypothyroidism. Eur J Endocrinol 2001;145:19-24.
92. Berge-Lefranc JL, Cartonzon G, Mattei MG, Passage E, Malezet-Desmoulins C, Lissitzky S. Localisation of the thyroglobulin gene by in situ hybridization to human chromosomes. Hum Genet 1985;69:28-31.
93. DeGroot U. Congenital defects in thyroid hormone formation and action. In: DeGroot LJ, ed. Endocrinology, 3rd ed. Philadelphia: WB Saunders, 1995:871.
94. Targovnik HM, Frechtel GD, Mendive FM, Vono J, Cochaux P, Vassart G, Medeiros-Neto G. Evidence for the segregation of three different mutated alleles of the thyroglobulin gene in a Brazilian family with congenital goiter and hypothyroidism. Thyroid 1998;8:291-7.
95. Van de Graff SAR, Ris-Stalpers C, Veenboer GJM, Cammengo M, Santos C, Torgovnik HM, de Vijlder JM, Medeiros-Neto G. A premature stop codon in thyroglobulin messenger RNA results in familial goiter and moderote hypothyroidism. J Clin Endocrinol Metab 1999;84:2537-42.
96. Hishinuma A, Takomatsu J, Ohyamo Y, Yokozawo T, Konno Y, Kuma K, Yoshido S, Motsuura N, Ieiro T. Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin couse a defect in intracellulor transport of thyroglobulin in patients with congenital goiter and the variant type of odenomotous goiter. J Clin Endocrinol Metab 1999;84:1438-44.
97. Kim PS, Hossain SA, Park Y-N, Lee I, Yoo S-E, Arvan P. A single amino acid change in the acerylcholinesterase-like domain of thyroglobulin causes congenital goitre with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc Natl Acad Sci USA 1998;95:9909-13.
98. Medeiros-Neto G, Kim PS, Yoo SE, Vono J, Targovnik H, Camargo R, Hossain SA, Arvan P. Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 1996;98:2838-44.
99. Kim PS, Kwon O-Y, Arvan P. An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J Cell Biol 1996;133:517-27.
100. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996;379:458-60.
101. Smanik PA, Ryu K-Y, Theil KS, Mazzaferri EL, Jhiang SN. Expression, exon· intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997;138:3555-8.
102. Wolff J. Congenital goiter with defective iodide transport. Endocr Rev 1983,4:240-54.
103. - symporter. Nat Genet 1997;16:124-5.
104. Kosugi S, Sato Y, Matsuda A, Ohyama Y, Fujieda K, Inomata H, Kameya T, Isozaki O, Jhiang SM. High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures. J Clin Endocrinol Metab 1998;83:4123-9.
105. Pohlenz J, Duprez L, Weiss RE, Vassart G, Refetoff S, Costagliola S. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab 2000;85:2366-9.
106. Reardon W, Trembath RC. Pendred syndrome. J Med Genet 1996;33:1037-40.
107. Mondini C. Anatomic surdi nati sectio: de Boroniensi scientarium et artium instituto otque acedemia commentarii. Bononiae 1791;7:419-31.
108. Reardon W, O'Mahoney CF, Tremboth R, Jon H, Phelps PD. Enlarged vestibular aqueduct: a radiological marker of Pendred syndrome, and mutation of the PDS gene. Q J Med 2000;93:99-104.
109. Batsakis JG, Nishiyama RH. Deafness with sporadic goitre. Arch Otolaryngol 1962;76:401-6.
110. Masmoudi S, Charfedine L, Hmani M, Grati M, Ghorbel AM, Elgaied-Boulila A, Drira M, Hardelin J-P, Ayadi H. Pendred syndrome: pnenotypic variability in two families carrying the same PDS missense mutation. Am J Med Genet 2000;90:38-44.
111. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heymon M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411-22.
112. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, Kohn LD, Green ED. Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 2000;14:839-45.
113. Scott DA, Wang R, Kreman TM, Andrews M, McDonald JM, Bishop JR, Smith RJH, Karniski LP, Sheffield VC. Functional differences of the PDS gene products are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet 2000;9:1709-15.
114. Caillou B, Dupuy C, Lacroix L, Nocero M, Talbot M, Ohayon R, Deme D, Bidart J-M, Schlumberger M, Virion A. Expression of reduced nicotinamide adenine dinucleotide phosphate oxidose (TroX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 2001;86:3351-8.
115. Corvilain B, Van Sande J, Laurent E, Dumont JE. The H2O2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 1991;128:779-85.
116. Pachucki J, Wang D, Christophe D, Miot F. Structural and functional characterization of two humon ThOX/Duox genes and their 5′ flanking regions. Mol Cell Endocrinol 2004;214:53-62.
117. Moreno JC, Bikker H, Kempers MJ, von Trotsenburg AS, Boas F, de Vijlder JJ, Vulsma T, Ris-Stalpers C. Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenitol hypothyroidism. N Engl J Med 2002;347:95-102.
118. Friesema EC, Ganguly S, Abdollo A, Manning Fox JE, Halestrop AP, Visser TJ. Identification of monocorboxylote transporter 8 os a specific thyroid hormone transporter. J Biol Chem 2003;278:40128-35.
119. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refefoff S. A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004;74:168-75
120. Erratum in: Am J Hum Genet 2004;74:598
121. Agrawal P, Ogilvy-Stuart A, Lees C. Intrauterine diagnosis and management of congenital hypothyroidism. Ultrasound Obstet Gynecol 2002;19:501-5.
122. Becks GP, Burrow GN. Diagnosis and treatment of thyroid disease during pregnancy. In: DeGroof U, Besser M, Burger HG, Jameson JL, Loriaux DL, Marshall JC, Odell WD Potts JT, Rubenstein AAAH, eds. Endocrinology, 3rd ed. Philadelphia: WB Saunders, 1995:799-820.
123. Kohn LD, Harii N. Thyrotropin receptor autoantibodies (TSHRAbs): epitopes, origins and clinical significance. Autoimmunity 2003;36:331-7.
124. Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S. Congenital hypothyroidism due to mutations in the sodium/iodide symporter. J Clin Invest 1998;101:1028-35.
125. Bongers-Schokking JJ, Koot HM, Wiersmo D, Verkerk PH, de Mulnck Keizer-Shramo SMPF. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000;136:292-7.
126. Derksen-Lubsen G, Verkerk PH. Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature dota. Pediatr Res 1996;39:561-6.
127. Dubuis JM, Glorieux J, Richer F, Deal CL, Dussault JH, Van Vliet G. Outcome of severe congenital hypothyroidism: closing the developmental gop with early high dose levothyroxine treatment. J Clin Endocrinol Metab 1996;81:222-7.
128. Heyerdahl S, Kase BF, Lie SO. Intellectual development in children with congenital hypothyroidism in relation to recommended thyroxine treatment. J Pediatr 1991;18:850-7.
129. Tillotson SL, Fuggle PW, Smith I, Ades AE, Grant DB. Relation between biochemical severity and intelligence in early treated congenital hypothyroidism: a threshold effect. BMJ 1994;309:440-5.
130. Manley NR, Capecchi MR. The role of Hoxa-3 in mouse thymus and thyroid development. Development 1995;121:1989-2003.
131. de la Chapelle A, Herva R, Koivisto M, Aula P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet 1981;57:253-6.
132. Pueblitz S, Weinberg AG, Albores-Soavedra J. Thyroid C cells in the DiGeorge onomaly: a quantitative study. Pediotr Pathol 1993;13:463-73.
133. Meunier D, Aubin J, Jeonnotte L. Perturbed thyroid morphology and transient hypothyroidism symptoms in Hoxa5 mutant mice. Dev Dyn 2003;227:367-78.
134. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. Nkx-2. 5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants, Development 1993;119:419-31.
135. Roberts HE, Moore CA, Fernhoff PM, Brown AL, Khoury MJ. Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979-1992. Am J Med Genet 1997;71:29-32.